|
Name |
Longichalasin B
|
Molecular Formula | C30H37NO4 | |
IUPAC Name* |
[(1R,2R,7S,11R,12S,14S,15R,16S)-16-benzyl-12-hydroxy-5,7,14-trimethyl-13-methylidene-18-oxo-17-azatricyclo[9.7.0.01,15]octadeca-3,5,9-trien-2-yl] acetate
|
|
SMILES |
C[C@H]1CC=C[C@H]2[C@@H](C(=C)[C@H]([C@@H]3[C@@]2([C@@H](C=CC(=C1)C)OC(=O)C)C(=O)N[C@H]3CC4=CC=CC=C4)C)O
|
|
InChI |
InChI=1S/C30H37NO4/c1-18-10-9-13-24-28(33)21(4)20(3)27-25(17-23-11-7-6-8-12-23)31-29(34)30(24,27)26(35-22(5)32)15-14-19(2)16-18/h6-9,11-16,18,20,24-28,33H,4,10,17H2,1-3,5H3,(H,31,34)/t18-,20+,24-,25-,26+,27-,28+,30+/m0/s1
|
|
InChIKey |
GGQJVEJLGIJFPD-NUPIXCJZSA-N
|
|
Synonyms |
Longichalasin B
|
|
CAS | NA | |
PubChem CID | 156581992 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 475.6 | ALogp: | 4.2 |
HBD: | 2 | HBA: | 4 |
Rotatable Bonds: | 4 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 75.6 | Aromatic Rings: | 4 |
Heavy Atoms: | 35 | QED Weighted: | 0.475 |
Caco-2 Permeability: | -4.911 | MDCK Permeability: | 0.00002790 |
Pgp-inhibitor: | 0.828 | Pgp-substrate: | 0.769 |
Human Intestinal Absorption (HIA): | 0.023 | 20% Bioavailability (F20%): | 0.038 |
30% Bioavailability (F30%): | 0.007 |
Blood-Brain-Barrier Penetration (BBB): | 0.757 | Plasma Protein Binding (PPB): | 82.61% |
Volume Distribution (VD): | 1.994 | Fu: | 18.08% |
CYP1A2-inhibitor: | 0.09 | CYP1A2-substrate: | 0.08 |
CYP2C19-inhibitor: | 0.645 | CYP2C19-substrate: | 0.505 |
CYP2C9-inhibitor: | 0.767 | CYP2C9-substrate: | 0.058 |
CYP2D6-inhibitor: | 0.03 | CYP2D6-substrate: | 0.195 |
CYP3A4-inhibitor: | 0.908 | CYP3A4-substrate: | 0.361 |
Clearance (CL): | 8.671 | Half-life (T1/2): | 0.391 |
hERG Blockers: | 0.348 | Human Hepatotoxicity (H-HT): | 0.815 |
Drug-inuced Liver Injury (DILI): | 0.137 | AMES Toxicity: | 0.227 |
Rat Oral Acute Toxicity: | 0.88 | Maximum Recommended Daily Dose: | 0.988 |
Skin Sensitization: | 0.721 | Carcinogencity: | 0.105 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.01 |
Respiratory Toxicity: | 0.961 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC006059 | 1.000 | D01TSI | 0.250 | ||||
ENC003955 | 0.806 | D06CWH | 0.248 | ||||
ENC003300 | 0.766 | D0OB1J | 0.245 | ||||
ENC004026 | 0.752 | D0IN7I | 0.245 | ||||
ENC004468 | 0.750 | D0TB8C | 0.243 | ||||
ENC004745 | 0.750 | D09NNH | 0.243 | ||||
ENC005441 | 0.644 | D0V3ZA | 0.243 | ||||
ENC005506 | 0.634 | D0G1VX | 0.241 | ||||
ENC005175 | 0.634 | D0R1BD | 0.240 | ||||
ENC003763 | 0.634 | D0A5LH | 0.238 |